Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2026-01-05 @ 5:12 PM
Study NCT ID:
NCT03462966
Status:
TERMINATED
Last Update Posted:
2022-09-13
First Post:
2017-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rifaximin on Visceral Hypersensitivity
Sponsor:
Cedars-Sinai Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-19
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-20
First Submit QC Date:
None
Study First Post Date:
2018-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-02-11
Results First Submit QC Date:
None
Results First Post Date:
2022-09-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-18
Last Update Post Date:
2022-09-13
Last Update Post Date Type:
ACTUAL